tiprankstipranks
RegeneRx Biopharmaceuticals (RGRX)
OTHER OTC:RGRX
US Market
RGRX
RegeneRx Biopharmaceuticals
RESEARCH TOOLSreports

RegeneRx Biopharmaceuticals (RGRX) Financial Statements

84 Followers

RegeneRx Biopharmaceuticals Financial Overview

RegeneRx Biopharmaceuticals's market cap is currently $1.65K. The company's EPS TTM is $-0.0091; its P/E ratio is >-0.01; RegeneRx Biopharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 76.76K$ 76.76K$ 76.76K$ 76.76K$ 69.67K
Gross Profit$ 76.76K$ 70.12K$ 71.84K$ 76.70K$ 69.58K
Operating Income$ -1.40M$ -1.33M$ -1.29M$ -1.26M$ -1.32M
EBITDA$ -1.40M$ 56.00K$ -1.29M$ -1.25M$ -1.90M
Net Income$ -1.73M$ -1.60M$ -1.52M$ -1.40M$ -1.99M
Balance Sheet
Cash & Short-Term Investments$ 290.89K$ 1.23M$ 427.90K$ 639.92K$ 237.26K
Total Assets$ 382.18K$ 1.28M$ 551.79K$ 711.76K$ 281.04K
Total Debt$ 1.45M$ 1.16M$ 1.03M$ 735.08K$ 54.75K
Net Debt$ 1.16M$ -66.69K$ 598.33K$ 95.17K$ -182.51K
Total Liabilities$ 3.83M$ 3.51M$ 3.38M$ 3.05M$ 2.49M
Stockholders' Equity$ -3.45M$ -2.23M$ -2.82M$ -2.34M$ -2.21M
Cash Flow
Free Cash Flow$ -940.72K$ -990.30K$ -1.01M$ -1.14M$ -888.29K
Operating Cash Flow$ -940.72K$ -990.30K$ -1.01M$ -1.14M$ -888.29K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 1.79M$ 794.91K$ 1.54M$ 943.85K
Currency in USD

RegeneRx Biopharmaceuticals Earnings and Revenue History

Income Statement >

RegeneRx Biopharmaceuticals Debt to Assets

Balance Sheet >

RegeneRx Biopharmaceuticals Cash Flow

Cash Flow >

RegeneRx Biopharmaceuticals Forecast EPS vs Actual EPS

Earnings >